These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro fertilisation. A review of drug therapy and clinical management. Jennings JC; Moreland K; Peterson CM Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126 [TBL] [Abstract][Full Text] [Related]
3. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression. Branigan EF; Estes MA Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017 [TBL] [Abstract][Full Text] [Related]
4. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles. Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975 [TBL] [Abstract][Full Text] [Related]
5. IVF: past and future. Jones HW Reprod Biomed Online; 2003; 6(3):375-81. PubMed ID: 12735878 [TBL] [Abstract][Full Text] [Related]
6. Comparison of human menopausal gonadotropin stimulation with and without clomiphene for in-vitro fertilisation in poor-responders. Oride A; Kanasaki H; Miyazaki K J Obstet Gynaecol; 2015 Feb; 35(2):163-7. PubMed ID: 25058620 [TBL] [Abstract][Full Text] [Related]
7. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF. von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520 [TBL] [Abstract][Full Text] [Related]
8. The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix. Tavaniotou A; Albano C; Van Steirteghem A; Devroey P Reprod Biomed Online; 2003 Jun; 6(4):421-6. PubMed ID: 12831586 [TBL] [Abstract][Full Text] [Related]
9. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization. Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467 [TBL] [Abstract][Full Text] [Related]
10. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles. Albuquerque LE; Saconato H; Maciel MC Cochrane Database Syst Rev; 2005 Jan; (1):CD002808. PubMed ID: 15674898 [TBL] [Abstract][Full Text] [Related]
11. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles. Albuquerque LE; Saconato H; Maciel MC Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658 [TBL] [Abstract][Full Text] [Related]
12. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization. Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119 [TBL] [Abstract][Full Text] [Related]
13. An artificially induced follicle stimulating hormone surge at the time of human chorionic gonadotrophin administration in controlled ovarian stimulation cycles has no effect on cumulus expansion, fertilization rate, embryo quality and implantation rate. Vermeiden JP; Roseboom TJ; Goverde AJ; Suchartwatnachai C; Schoute E; Braat DD; Schats R Hum Reprod; 1997 Jul; 12(7):1399-402. PubMed ID: 9262265 [TBL] [Abstract][Full Text] [Related]
14. Placental protein 14 concentrations in circulation related to hormonal parameters and reproductive outcome in women undergoing IVF/ICSI. Westergaard LG; Yding Andersen C; Erb K; Laursen SB; Rasmussen PE; Rex S; Teisner B Reprod Biomed Online; 2004 Jan; 8(1):91-8. PubMed ID: 14759294 [TBL] [Abstract][Full Text] [Related]
15. Experience with a new fixed-stimulation protocol without hormone determinations for programmed oocyte retrieval for in-vitro fertilization. Kemeter P; Feichtinger W Hum Reprod; 1989 Nov; 4(8 Suppl):53-8. PubMed ID: 2515212 [TBL] [Abstract][Full Text] [Related]
16. Development of in vitro fertilization in the United States: a conversation between Zev Rosenwaks and Jairo E. Garcia. Garcia JE; Rosenwaks Z Fertil Steril; 2018 Jul; 110(1):14-18. PubMed ID: 29980255 [TBL] [Abstract][Full Text] [Related]
17. In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review. Trew GH; Brown AP; Gillard S; Blackmore S; Clewlow C; O'Donohoe P; Wasiak R Reprod Biol Endocrinol; 2010 Nov; 8():137. PubMed ID: 21059191 [TBL] [Abstract][Full Text] [Related]
18. Establishing pregnancies after follicular stimulation for IVF with clomiphene citrate and human menopausal gonadotrophin only. Fishel SB; Webster J; Faratian B; Jackson P; Shelton K; Johnson J Hum Reprod; 1991 Jan; 6(1):106-12. PubMed ID: 1908488 [TBL] [Abstract][Full Text] [Related]
19. Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients. Benadiva CA; Davis O; Kligman I; Liu HC; Rosenwaks Z J Assist Reprod Genet; 1995 Jan; 12(1):8-12. PubMed ID: 7580013 [TBL] [Abstract][Full Text] [Related]
20. [Ovulation induction by endogenous LH released by the administration of an LHRH agonist after follicular stimulation for in vitro fertilization]. Emperaire JC; Ruffié A; Audebert AJ J Gynecol Obstet Biol Reprod (Paris); 1992; 21(5):489-94. PubMed ID: 1401761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]